Literature DB >> 33451011

Complement as a Therapeutic Target in Systemic Autoimmune Diseases.

María Galindo-Izquierdo1, José Luis Pablos Alvarez1.   

Abstract

The complement system (CS) includes more than 50 proteins and its main function is to recognize and protect against foreign or damaged molecular components. Other homeostatic functions of CS are the elimination of apoptotic debris, neurological development, and the control of adaptive immune responses. Pathological activation plays prominent roles in the pathogenesis of most autoimmune diseases such as systemic lupus erythematosus, antiphospholipid syndrome, rheumatoid arthritis, dermatomyositis, and ANCA-associated vasculitis. In this review, we will review the main rheumatologic autoimmune processes in which complement plays a pathogenic role and its potential relevance as a therapeutic target.

Entities:  

Keywords:  complement system; pathogenesis; rheumatic autoimmune diseases; therapeutic blockade

Year:  2021        PMID: 33451011      PMCID: PMC7828564          DOI: 10.3390/cells10010148

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  187 in total

1.  Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE).

Authors:  M Kawano; T Seya; I Koni; H Mabuchi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 2.  Complement in ANCA-associated vasculitis: mechanisms and implications for management.

Authors:  Min Chen; David R W Jayne; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-03-20       Impact factor: 28.314

3.  Complement-mediated thrombotic microangiopathy associated with lupus nephritis.

Authors:  Mi Hee Park; Nicholas Caselman; Scott Ulmer; Ilene Ceil Weitz
Journal:  Blood Adv       Date:  2018-08-28

4.  Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency.

Authors:  B H Petersen; T J Lee; R Snyderman; G F Brooks
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

5.  How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease.

Authors:  Isao Matsumoto; Mariana Maccioni; David M Lee; Madelon Maurice; Barry Simmons; Michael Brenner; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

6.  Microvascular deposition of complement membrane attack complex in dermatomyositis.

Authors:  J T Kissel; J R Mendell; K W Rammohan
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

7.  Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis.

Authors:  G Moxley; S Ruddy
Journal:  Arthritis Rheum       Date:  1985-10

8.  Complement activation and effect of eculizumab in scleroderma renal crisis.

Authors:  Arnaud Devresse; Selda Aydin; Moglie Le Quintrec; Nathalie Demoulin; Patrick Stordeur; Catherine Lambert; Sara Gastoldi; Yves Pirson; Michel Jadoul; Johann Morelle
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.

Authors:  Anna Schubart; Karen Anderson; Nello Mainolfi; Holger Sellner; Takeru Ehara; Christopher M Adams; Aengus Mac Sweeney; Sha-Mei Liao; Maura Crowley; Amanda Littlewood-Evans; Sophie Sarret; Grazyna Wieczorek; Ludovic Perrot; Valérie Dubost; Thierry Flandre; Yuzhou Zhang; Richard J H Smith; Antonio M Risitano; Rajeshri G Karki; Chun Zhang; Eric Valeur; Finton Sirockin; Bernd Gerhartz; Paulus Erbel; Nicola Hughes; Thomas M Smith; Frederic Cumin; Upendra A Argikar; Börje Haraldsson; Muneto Mogi; Richard Sedrani; Christian Wiesmann; Bruce Jaffee; Jürgen Maibaum; Stefanie Flohr; Richard Harrison; Jörg Eder
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-29       Impact factor: 11.205

Review 10.  Complement in the Initiation and Evolution of Rheumatoid Arthritis.

Authors:  V Michael Holers; Nirmal K Banda
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

View more
  3 in total

1.  Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.

Authors:  Thao H P Nguyen; Ingrid Hokstad; Morten Wang Fagerland; Tom Eirik Mollnes; Ivana Hollan; Mark W Feinberg; Gunnbjørg Hjeltnes; Gro Ø Eilertsen; Knut Mikkelsen; Stefan Agewall
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

Review 2.  Anaphylatoxins spark the flame in early autoimmunity.

Authors:  Jovan Schanzenbacher; Jörg Köhl; Christian M Karsten
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

3.  Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis.

Authors:  Selene Pérez-García; Valentina Calamia; Tamara Hermida-Gómez; Irene Gutiérrez-Cañas; Mar Carrión; Raúl Villanueva-Romero; David Castro; Carmen Martínez; Yasmina Juarranz; Francisco J Blanco; Rosa P Gomariz
Journal:  Int J Mol Sci       Date:  2021-06-16       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.